Výsledky vyhledávání - "Gislaine Villarta Capeleti Dib"

Active postmarketing surveillance: Results from a manufacturer's patient support program for patients under treatment with the first biosimilar trastuzumab (MYL-1401O) approved in Brazil

Autor: Emanuela Lopez Fernandes Saraiva, Thais Tiemi Wepeck Oliveira Watanabe, Jaqueline Amália de Paulo, Gislaine Villarta Capeleti Dib, Allisson Monteiro da Silva

Publikováno v: Journal of Clinical Oncology. 37:e14000-e14000

e14000 Background: The development of biosimilars is increasing around the world, and facilitates patient’s access to these high-tech therapies. Active pharmacovigilance is considered one of the main tools for monitoring the safety of biologics and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2daef4395871c322e869ad59ce574b77
https://doi.org/10.1200/jco.2019.37.15_suppl.e14000

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání